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Abstract
Background: Studies suggest that mindfulness-based interventions can improve anxiety, depression and stress in patients with multiple 
sclerosis (MS). However, no study investigated the effectiveness of this method in patients with a combination of problems such as 
depression, anxiety and stress simultaneously. However, comorbidities of depression and anxiety in MS are prevalent.
Objectives: This study aimed to assess the effects of mindfulness-based stress reduction (MBRS) on anxiety, depression and stress in 
women with multiple sclerosis.
Patients and Methods: This randomized controlled clinical trial was performed in 2013 in Ahvaz MS Society. Forty eight patients were 
selected by convenient sampling and randomly assigned in experimental and control groups. The patients in the two groups filled out 
depression, anxiety and stress scale (DASS-21) at initiation of study, 8 weeks later and 1 month after the end of intervention. The experimental 
group received 8 sessions of MBRS, while the control group treated as usual. Finally, data of 40 patients analyzed using t-test, chi square 
and repeated measures analysis of variance.
Results: In the MBSR group, the mean depression, anxiety and stress were reduced significantly (P < 0.001). The mean depression score 
was 8.35 ± 1.78 before the intervention and reduced to 4.80 ± 0.83 and 4.45 ± 0.60 after the intervention and follow-up (P < 0.001). Also 
the mean anxiety score was 8.90 ± 1.97 before the intervention, which was significantly reduced to 4.70 ± 1.38 and 4.55 ± 0.99 after the 
intervention and follow-up (P < 0.001). The mean stress score was also 8.80 ± 2.35 before treatment and 4.80 ± 1.67 and 4.70 ± 1.34 after the 
intervention and follow-up (P < 0.001).
Conclusions: This study showed that MBSR training can reduce mean depression, anxiety and stress scores in patients with MS. These 
findings suggest that MBSR is useful for psychological problems such as depression, anxiety and stress in patients with MS.
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1. Background
Multiple sclerosis (MS) is a neurologic illness in which 
the myelin covering the central nervous system is injured 
(1). Chronic and disabling diseases such as MS have nu-
merous psychiatric consequences such as anxiety and de-
pression (2). According to the Iranian Multiple Sclerosis 
Society, in 2013 there were about 70000 patients with MS 
in Iran (3). The progression of MS is accompanied with se-
ries of physical and psychological problems that affect all 
of daily activities such as dressing, taking a bath and self-
care and eventually reduces individual’s autonomy, psy-
chological wellbeing and quality of life (QOL) (4). Studies 
have shown high levels of anxiety, stress and mood disor-
ders including depression in these patients. It is reported 
that more than a third of patients with MS have anxiety 
disorders (5, 6). Moreover, about 10% and 8.6% of them 
have panic disorder and obsessive compulsive disorder, 
respectively (5, 6). A recent study reported that lifetime 
prevalence of major depressive disorder in patients with 
MS is 22.8% to more than 50% (2). Another study reported 
that approximately 48% of patients with MS experience 
anxiety, stress and depression in the first year after the 
diagnosis (7). Individuals with anxiety disorder are more 
likely to be female, have a history of depression, drink ex-
cessively, have higher levels of social stress and contem-
plated suicide (8).
Presently no cure exists for MS. A combination of phar-
macological and non-pharmacological managements is 
usually implemented in an individualized, organized, and 
rational program to delay the progression of the disease, 
manage chronic symptoms, and treat acute exacerbations 
(9). Considering the adverse effects of medications, non-
pharmacological methods are suggested for reducing 
anxiety and stress in patients with MS. Non-pharmacolog-
ical therapies such as exercise, hydrotherapy, nutritional 
therapy, medicinal plants, energy therapy, occupational 
therapy, acupuncture, acupressure, relaxation therapy 
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and meditation are among the methods used to reduce 
physical and psychological symptoms of MS (9-11). One of 
the new treatments in the field of psychotherapy is mind-
fulness-based stress reduction (MBSR), which is under 
category of meditation. This approach was introduced by 
Kabat-Zinn (12) in the 1970s and since then, it was applied 
in many problems such as coping with stress, illness and 
pain in patients with heart disease, cancer, AIDS (acquired 
immune deficiency syndrome), chronic pain, stress-re-
lated gastrointestinal problems, headaches, high blood 
pressure, sleep disorders, depression, and anxiety (12-16). 
However, some studies reported that MBSR has large ef-
fects on stress reduction, but is moderately effective on 
anxiety, depression and QOL, and has little effects on burn-
out (17). Moreover, only a few studies are available on the 
effectiveness of MBSR in patients with MS. These studies 
showed that MBRS can improve psychological symptoms 
of patients (18-20). These studies suggest that mindfulness-
based interventions can improve QOL, anxiety, depression, 
physical health, fatigue, pain, and health-related QOL in 
patients with MS and that the effects lasted up to 6 months 
after the intervention. However, each of these studies in-
vestigated only the effects of MBRS of isolated variables 
and no study investigated the effectiveness of this method 
in patients with a combination of problems such as de-
pression, anxiety and stress simultaneously. However, co-
morbidities of depression and anxiety in MS are prevalent. 
In addition, some of the studies conducted on patients 
with MS had no control group (21, 22).
2. Objectives
This study aimed to assess the effects of mindfulness-
based stress reduction on anxiety, depression and stress 
in women with multiple sclerosis in Ahvaz.
3. Materials and Methods
3.1. Participants and Procedure
This randomized controlled clinical trial was performed 
in 2014 in Ahvaz MS Society. The study population includ-
ed all female patients aged 20 - 50 years with MS referred 
to Ahvaz MS society from January to June 2014.
The sample size was calculated based on a previous 
study in which Grossman et al. investigated the impact of 
mindfulness training on QOL, depression and fatigue in 
patients with MS and reported that mean and standard 
deviation of depression before the intervention was 16.33 
± 10.46 and changed to 5.29 ± 7.07 after the intervention 
(23). According to 95% confidence and test power of 90%, 
using Cohen’s formula, 15 subjects were estimated to be 
needed in each group. However, we recruited 24 patients 
in each group to achieve more reliable results.
After sample size calculation, reviewing the files of pa-
tients with MS in Ahvaz MS society, 48 patients with inclu-
sion criteria were selected by convenient sampling. Then 
patients were called and invited to participate in the study. 
If a patient agreed to participate, he or she was invited to 
attend the study briefing session and if not, another pa-
tient was selected similarly. Then, using a random num-
ber table, they were assigned into experimental (MBSR) 
and control groups. The inclusion criteria were having a 
medical diagnosis of MS, having a minimum literacy of 
intermediate school level, not having a psychotic disorder 
(according to the structural clinical interview for DSM dis-
orders for Axis I; SCID-I administered by a clinical psycholo-
gist) and receiving no regular psychotherapy during the 
last 6 months. Exclusion criteria were having a relapsing 
MS and absence of more than two therapeutic sessions.
3.2. Instruments
The study instrument had two parts. The first part in-
cluded three questions on demographic information 
about age, education level and marital status. The second 
part was the 21-item Depression, Anxiety and Stress Scale 
(DASS-21). The DASS-21 was made in 1995 and has three 
subscales of depression, anxiety and stress (24). Each 
subscale consists of 7 items. Items 3, 5, 10, 13, 16, 17 and 21 
are related to depression; anxiety subscales are items 2, 
4, 7, 9, 15, 19 and 20 and stress subscales are items 1, 6, 8, 
11, 12, 14 and 18. Each item has a four-point Likert scale re-
sponse between 0 (never) and 3 (always). Therefore, each 
subscale has scores from 0 to 21. Higher scores in each 
subscale show a higher degree of anxiety, depression and 
stress. Evidence suggests that the convergent and dis-
criminant validity of DASS are sufficient (24). The validity 
of Iranian version of DASS-21 was previously confirmed. 
Its reliability was also evaluated through Cronbach’s al-
pha coefficient of 0.80, 0.76 and 0.77 for depression, anxi-
ety and stress subscales, respectively (25).
3.3. Procedures
In addition to the usual treatments for MS, the experi-
mental group received eight weeks of MBSR training week-
ly, according to the protocol developed by Kabat-Zinn (12) 
and Segal (26). The outline of the protocol is shown in Ta-
ble 1. However, the control group only received treatments 
as usual (TAU). The DASS-21 was administered to the experi-
mental group at pretest (before the intervention), post-
test (at the end of intervention) and two months after the 
end of intervention (follow-up). Patients in the TAU group 
were also invited to Ahvaz MS society to respond to the 
DASS-21 simultaneous with the MBSR group. Patients in the 
both groups completed the demographic questionnaire 
at baseline. Both groups were also received their routine 
drug treatments. All the MBRS sessions were held in Ahvaz 
MS Society and administered by a trained psychologist. 
Each session lasted for 120 minutes from 10 to 12 o’clock 
of Tuesdays. For participants who had missed one or two 
sessions, additional sessions were held. After finishing the 
study, all patients in the control group were also contacted 
and invited to voluntarily attend in MBSR sessions similar 
to those the experimental group had passed.
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Table 1. The Outline of the Mindfulness-Based Stress Reduction (According to Kabat-Zinn (12) and Segal et al. (26))
Session Contents of Each Session
1 Introducing the rules of group such as confidentiality, raisin exercise (Eating raisins with the full involvement of the senses of smell, taste, 
sight and touch), body scan practice (subjective evaluation of body parts, identifying stress and its relaxation), re-breathing training
2 Body scan practice, pleasant event calendar (writing daily events that induced positive emotions such as joy, pride and praise), being mind-
ful in all actions (doing tasks with focus on them through the five senses)
3 Mindful watching and hearing (focusing of watching and hearing without judgment), sitting meditation, three-minute breathing space, 
mindful walking, and unpleasant event calendar (writing daily events that induced negative emotions such as anxiety, sad, hate, anger, etc.)
4 Mindful watching and hearing, sitting meditation, definition of stress and its related body systems, responding to stress versus reaction to 
it (not acting immediately and rapidly when experiencing unpleasant emotions, such as anxiety)
5 Sitting meditation, breathing space, mindful metaphors, introducing the concept of “acceptance”, introducing anxiety worksheet
6 Sitting meditation, monitoring the emotions and thoughts, strengthen observer self (observing the internal events such as thoughts, emo-
tions, and bodily sensation without stocking on them)
7 Behavioral activation (identifying pleasure and important daily activities and doing them systematically), identifying actions to do in low-
mood periods
8 Review all prior sessions and their results for everyone
3.4. Ethical Considerations
The Research Ethics Committee of Azad University, Kho-
rasgan Branch approved this study (code of Ethical Review 
Committee was 25/5/1/3551 and the code of the project was 
486207). All participants were asked to sign an informed 
consent form and assured that their personal data would 
be confidential. Moreover, all participants were aware of 
the voluntary nature of their participation in the study 
and the right to withdraw from the study at any point. In 
addition, after completion of the study, the control group 
was invited to attend in similar MBSR training session.
3.5. Data Analysis
The repeated measures analysis of variance was used 
to compare MBSR and TAU groups regarding depression, 
anxiety and stress. Moreover, t-test was used to compare 
significant differences between mean age of the two 
groups. Chi-square test was used to compare other demo-
graphic variables such as marital status and education 
level in the two groups. P value less than 0.05 was consid-
ered statistically significant in all tests.
4. Results
 Table 2 shows demographic characteristics of the sub-
jects. Among 48 subjects, 4 ones were excluded from each 
group because of missing more than two sessions and 
not completing the DASS-21 (Figure 1).
Assessed for eligibility 
(n=63)
 
Randomized (n= 48)  
Excluded (n= 15)
 
Not meeting inclusion criteria (n= 7)
 
Declined to participate (n= 8)
Other reasons (n= 0)
Allocated to experimental group 
[MBRS (n= 24)]  
Allocated to control group 
[Treatment as usual (n= 24)]  
Lost to follow up (n=  4)  
Lost to follow up (n=  4)
Analyzed (n=  20)  Analyzed (n=  20)  
Figure 1. The Study Flow Diagram
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Table 2. Demographic Characteristics of Patients With MS in MBSR and TAU Groupsa
Variable MBSR TAU P Value
Age 5.77 ± 25.70 2.39 ± 24.85 .54b
Education level .88c
High school 10 (25) 11 (27.5)
Bachelor 10 (25) 9 (22.5)
Marital status .99c
Married 10 (25) 10 (25)
Single 10 (25) 10 (25)
Abbreviations: MBSR, mindfulness-based stress reduction; TAU, treatment as usual.
aData are presented as mean ± SD or No. (%).
bt-test.
cChi-square test.
Table 3. Comparison of Depression, Anxiety and Stress at Pretest, Posttest and Follow-Up in the Two Groupsa
Outcome Measure Pre-Test Post-Test Follow-Up P Value
Time Time × Group
Depression < .001 < .001
MBSR 8.35 ± 1.78 4.80 ± 0.83 4.45 ± 0.60
TAU 8.85 ± 1.64 8.65 ± 1.63 8.65 ± 1.34
Anxiety <.001 < .001
MBSR 8.90 ± 1.97 4.70 ± 1.38 4.55 ± 0.99
TAU 8.70 ± 1.92 8.60 ± 1.66 8.60 ± 1.56
Stress  < .001 < .001
MBSR 8.80 ± 2.35 4.80 ± 1.67 4.70 ± 1.34
TAU 9.10 ± 2.04 8.90 ± 1.71 8.85 ± 1.95
Abbreviations: MBSR, mindfulness-based stress reduction; TAU, treatment as usual.
aData are presented as mean ± SD.
4
5
6
7
8
9
Follow-upPosttestPretest
Depression in MBSR group
Depression in TAU group
Anxiety in MBSR group
Anxiety in TAU group
Stress in MBSR group
Stress in TAU group
Figure 2. Changes in Depression, Anxiety and Stress Mean Scores in TAU 
and MBSR Groups
No significant differences were observed between MBSR 
and TAU groups for demographic variables (Table 2).
 Table 3 provides mean scores of dependent variables (de-
pression, anxiety and stress) and comparison of them at 
pretest, posttest, and two-month follow-up. It shows that 
the mean depression, anxiety and stress scores in MBSR 
group were decreased in 2 phases (posttest and follow- up) 
compared to pretest. Although a little decrease was oc-
curred in scores of dependent variables in the TAU group, 
but they were not significant and did not continue in fol-
low-up. Figure 2 shows changes in depression, anxiety and 
stress mean scores in TAU and MBSR groups in 3 consecu-
tive measurements.
Mauchly’s test of sphericity showed the null hypothesis 
that the error covariance matrix of the orthonormalized 
transformed dependent variables is proportional to an 
identity matrix was not confirmed (Mauchly’s W = .551, 
Sig = 0.061). However, there was an interaction between 
group membership and therapeutic phase (or time) by 
Hotelling’s trace test (F = 33.681, Sig < 0.001). Changes 
in variables such as depression, anxiety and stress have 
been shown in three-phase treatment by Figure 2.
5. Discussion
This study showed that MBSR can reduce depression, 
anxiety and stress in patients with MS. These findings are 
consistent with the results of other previous studies (14-
16) and revealed benefits of MBRS in patients with MS.
Our study showed that MBSR can reduce depression in 
patients with MS. Depression is linked to neurological 
changes in the brain structure and function in persons 
with MS (27). Mindfulness leads to the activation of the 
area of the brain that is associated with positive emo-
tions and affects immunization function (28). In addi-
tion, mindfulness may reduce stress and mood dysregu-
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lation by empowering positive reappraisal and emotion 
regulation skills (29).
Mindfulness training through different mechanisms 
can reduce anxiety, depression and stress in patients with 
MS. First, one of the important causes of these psycho-
logical states is anxiety and depression due to pain that 
patients experience. In meditation, a basic technique in 
MBSR, patients are trained to focus on feeling pain in 
the body and joints without emotional reactions to the 
pain, just observing it. The observing can reduce emo-
tional responses (such as anxiety and depression) that 
evoke pain in MS (12) and mutually exacerbate their pain 
and lack of mobility. MBSR allows thoughts to come and 
go easily, without any attempt to alter, diminish or ex-
pand them. Through mindfulness training, participants 
learn to see their mental events (depression, anxiety and 
stress) as transient not reality. In this way, participants 
are confronted with the contents of positive and nega-
tive thoughts, but they are not drowned in thoughts of 
future or past that develop depression and anxiety/
stress, respectively. MBSR can create this ability through 
components such as acceptance of internal experiences 
(thoughts, depression, anxiety, stress and pain) and non-
judgmental awareness to them (30). MBSR through ev-
ery moment of awareness affects patient acceptance of 
internal experiences, which helps him or her decrease 
habitual problematic patterns of thinking, feeling and 
behavior. It shows new ways to respond and cope with 
internal and external problems (31). Second, focusing on 
breathing was used as a tool to live in the present and de-
tach the person from problematic internal experiences. 
In this way, patients trained to stop the cycle of rumina-
tion, depression (32), worry, anxiety and stress. Third, 
mindfulness-based stress reduction program teaches 
participants how to focus their awareness to everyday life 
that is full of pleasure and unpleased events. Mindfulness 
exercises are used throughout a day, so people can show 
good response to environmental stressors (12). Practic-
ing the mindfulness skills increase the ability of partici-
pants to tolerate negative emotional states (such as de-
pression and anxiety) and enable to deal effectively with 
them (32). Forth, MBSR can decrease depression, anxiety 
and stress by behavioral activation in patients with MS. 
MBSR helps people to do physical activity. For example, in 
one of the exercises called yoga, a person does stretching 
movements in the body, which increase awareness to the 
body and its status as a form of appropriate exercise for 
patients. The mindfulness exercises such as walking with 
mindfulness (mindful walking) are forms of behavioral 
activation. In mindful walking, patient by focusing on 
own individual five senses can decrease anxious and de-
pressive thoughts and emotions and increase pleasure. 
In a broader perspective, the treatment can enhance the 
QOL in patients.
Our study showed that patients with MS can reduce 
their depression, anxiety and stress by MBSR training. 
Moreover, MBSR is suggested as a suitable therapy for re-
ducing depression, anxiety and stress and can be used as 
a low-cost and accessible treatment for all medical staff 
working with MS patients, particularly nurses and psy-
chiatric nurses.
Limitations of the present study were using only female 
for sample. The small sample size and short duration of 
follow-up were other limitations in this study. Further 
studies with larger sample sizes and longer follow-up 
and in male patients are recommended.
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